Health authorities in England are launching a vaccination campaign targeting young people against meningitis B, a bacterial strain responsible for an outbreak in the Kent region. Approximately one million individuals are eligible for the free vaccine through the National Health Service, with nearly 90,000 doses already distributed and an additional 135,000 appointments scheduled for coming weeks.
The campaign focuses on 17 and 18-year-old students in sixth form, as well as individuals under 25 entering residential universities or further education colleges for the first time this autumn. Eligible groups include those born between specific dates and international students planning to study in England. The vaccine is administered in two doses, spaced at least 28 days apart, and both doses are recommended for maximum protection. Teenagers can book appointments through the NHS National Booking Service or visit participating high street pharmacies across England on a walk-in basis.
The vaccination effort was prompted by a significant outbreak in Kent in March, which resulted in 29 confirmed or suspected cases and two deaths. Health officials note that first-year university students face approximately seven times higher risk of infection compared to peers not attending university, attributed to increased social mixing and shared living arrangements. The infection spreads through close contact such as kissing, sharing beverages, or residing in proximity to infected individuals.
Meningitis B can cause severe complications including inflammation of the brain lining and blood poisoning, potentially resulting in life-threatening conditions, disabilities such as hearing loss or amputations, or death in some cases. While the vaccine does not contain live bacteria and cannot cause the disease, mild side effects like injection site reactions, fever, or headache may occur temporarily. The MenB vaccine was incorporated into routine childhood immunization programs for babies born after 1 July 2015, but older teenagers and young adults had not previously received routine protection.
Experts have recommended that government officials consider extending routine MenB vaccination to all teenagers around age 15 going forward. All constituent nations of the UK are implementing vaccination programs, with eligibility criteria varying slightly by region but generally including students completing final secondary school years in summer 2026.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI